Added Value of a Small Camera (Iriscope) in the Endoscopic Diagnosis of Peripheral Lung Nodules and Masses
NCT ID: NCT05445635
Last Updated: 2024-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
91 participants
INTERVENTIONAL
2022-06-02
2024-08-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Usually, the pathological diagnosis is obtained by bronchoscopy. However, peripheral bronchi cannot be seen after the fifth bronchial division as the diameter of the broncoscope is greated than the diameter of the bronchi. Therefore, the Iriscope was developed. It consists in a thin catheter with a mini-camera at its distal extremity.
The aime of this study is to evaluate the diagnostic yield of bronchoscopy guided by Iriscope in the setting of peripheral lung nodules and masses supect of malignancy, to compare the Iriscope to endobronchial radial ultrasonography (which is a validated technique to guide bronchoscopy in the setting of peripheral lung nodules and masses) and to evaluate the added value on the diagnostic yield by combining these 2 techniques.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High-definition Videobronchoscopy in Sarcoidosis
NCT04743596
EBUS-Miniprobes Sampling for Peripheral Lung Lesions
NCT03422744
Virtual Bronchoscopic Navigation to Increase Diagnostic Yield in Patients With Pulmonary Nodules
NCT05383105
Optimization of the Sensitivity of Histological Diagnosis of Pulmonary Nodules
NCT05230992
Added Value of Cone Beam CT Guidance to Electromagnetic Navigation Bronchoscopy for the Diagnosis of Pulmonary Nodule.
NCT05257382
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Iriscope
Iriscope
The use of Iriscope to improve the diagnostic yield of bronchoscopy in the setting of peripheral lung nodules
EBUS
Iriscope
The use of Iriscope to improve the diagnostic yield of bronchoscopy in the setting of peripheral lung nodules
Combined Iriscope + EBUS
Iriscope
The use of Iriscope to improve the diagnostic yield of bronchoscopy in the setting of peripheral lung nodules
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iriscope
The use of Iriscope to improve the diagnostic yield of bronchoscopy in the setting of peripheral lung nodules
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Coagulopathy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erasme University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olivier Taton
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier Taton, Resident
Role: PRINCIPAL_INVESTIGATOR
Hôpital Erasme, Université Libre de Brussels, Brussels, Belgium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erasme Hospital
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P2021/770
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.